What Is HPLC and How Is It Used to Test Peptide Purity?

Before a researcher places a peptide compound into any in vitro assay or preclinical model, one question must be answered: how pure is it? High-performance liquid chromatography — HPLC — is the analytical technique laboratories rely on to answer that question with precision. The purity figure printed on a Certificate of Analysis is only as meaningful as the methodology behind it, and HPLC is that methodology.

What Is HPLC?

High-performance liquid chromatography is a form of column chromatography in which a liquid mobile phase carries a dissolved sample through a tightly packed stationary phase at high pressure. As different molecules in the sample interact with the stationary phase to varying degrees, they travel through the column at different speeds and exit — or elute — at different times. A detector at the end of the column records a signal as each component passes, producing a readout called a chromatogram.

The technique evolved in the 1960s when engineers discovered that packing smaller, more uniform particles under pressure dramatically increased both the speed and resolution of separations. Today, ultra-high-performance liquid chromatography (UHPLC) describes instruments that operate at even higher pressures with sub-2-micron columns, offering faster runtimes and sharper peaks. HPLC is especially well suited to peptides because the technique can resolve closely related sequences that differ by only a single amino acid modification. For a primer on what peptides are at the molecular level, see our guide on what a peptide is.

The Reverse-Phase Setup Most Commonly Used for Peptides

Several HPLC modes exist, but reverse-phase HPLC (RP-HPLC) dominates peptide analysis. In reverse-phase systems the stationary phase is hydrophobic — typically silica particles bonded with C18 (octadecyl) or C8 hydrocarbon chains — while the mobile phase starts aqueous and becomes progressively more organic (usually acetonitrile) over the course of the run. This gradient elution means that hydrophilic peptides elute early, when the mobile phase is mostly water, and hydrophobic peptides elute later as the organic content rises.

A UV detector set at 214 nm is standard: peptide bonds absorb at this wavelength, enabling detection of virtually any peptide. Some laboratories also monitor at 280 nm to capture tryptophan and tyrosine residues. The area under each peak is proportional to the amount of that component, which is how purity percentages are calculated. Our article on how peptide synthesis works explains the solid-phase steps that leave behind truncated sequences and reagent residues — exactly the impurities HPLC is designed to detect.

Reading an HPLC Chromatogram

A typical RP-HPLC chromatogram shows one dominant peak — the target compound — flanked by smaller peaks representing impurities. The purity percentage is the area of the main peak divided by the total area of all detected peaks, multiplied by 100. A result of 98% means 98% of the UV-absorbing material co-elutes with the target; the remaining 2% elutes at other retention times.

"Purity by HPLC reflects the proportion of UV-absorbing material that co-elutes with the main compound — it does not independently confirm the compound's identity, which is why HPLC and mass spectrometry are routinely paired."

Several practical details matter when interpreting results:

• Peak symmetry: A symmetric, Gaussian-shaped main peak indicates a clean separation. Tailing or fronting can suggest column overloading or secondary interactions.
• Baseline resolution: Peaks that are well separated from one another allow accurate area integration. Overlapping peaks inflate apparent purity.
• Gradient conditions: Two labs can report different purity values for the same batch if they use different column lengths, particle sizes, gradient slopes, or flow rates. Always review the method conditions alongside the result.
• Injection concentration: Very dilute injections can cause minor impurities to fall below the detector's limit of detection, artificially inflating the apparent purity figure.

For a practical walkthrough of how to interpret the full document these results appear in, see our guide on how to read a certificate of analysis.

HPLC vs. Mass Spectrometry: Complementary, Not Interchangeable

HPLC measures how much of each component is present; mass spectrometry (MS) measures what each component is by determining molecular mass. Used together as LC-MS, the two techniques provide both identity confirmation and quantitative purity in a single experiment. HPLC alone cannot confirm the main peak is the correct peptide; MS alone cannot reliably quantify purity because ionization efficiency varies between molecules.

Property	HPLC (UV)	Mass Spectrometry
What it measures	Relative peak areas (purity %)	Molecular mass (identity)
Confirms identity?	No	Yes
Quantifies impurities?	Yes (UV-absorbing species)	Not directly
Detects non-UV impurities?	No	Sometimes (depends on ionization)
Cost / throughput	Lower cost, higher throughput	Higher cost, slower throughput

Reputable suppliers pair both methods so researchers can verify identity and purity independently. Our companion article on mass spectrometry in peptide research covers the MS side in depth.

Why Purity Grade Matters in Preclinical Research

Research integrity depends on knowing what is actually in a sample. If a peptide preparation is 80% pure rather than 98% pure, the remaining 20% consists of unknown compounds — truncated sequences, modified side chains, or residual reagents — that may have biological activity of their own in a cell culture or animal model, confounding attribution of any observed effect.

Preclinical studies routinely specify a minimum purity threshold (often ≥95% or ≥98% by HPLC) in their materials sections. Researchers examining BPC-157, ipamorelin, or any other peptide in cellular or animal models should review the HPLC trace — not just the summary percentage — before committing a batch to study. Even a high-percentage result can hide a shoulder peak that integration software attributes to the main compound rather than treating as a distinct impurity. All such investigations are conducted strictly in laboratory settings with research-grade materials; none of the evidence discussed constitutes a claim of safety or efficacy for human use.

What a Quality HPLC Report Should Contain

A rigorous HPLC report accompanying research-grade peptides should include:

1. The chromatogram image itself — not just the summary percentage. The visual trace allows independent assessment of peak shape and the presence of shoulder peaks.
2. Method parameters — column type, mobile phase, gradient program, flow rate, UV wavelength, and injection volume, so results can be replicated and compared across batches.
3. Retention time of the main peak as a batch-to-batch consistency check.
4. Integration table listing the area and percentage for every detected peak, not only the main compound.
5. Calibration records from an accredited third-party laboratory confirming the data was not generated on unvalidated equipment.

When testing is performed by an ISO-accredited laboratory independent of the supplier, it adds assurance that results have not been influenced by commercial incentives. Our article on third-party lab testing for peptides explains what independent verification means in practice. Researchers sourcing compounds for laboratory work can browse the full catalog and download the corresponding certificate of analysis before initiating any study.

Limitations of HPLC in Peptide Characterization

HPLC is powerful but not omniscient. Several classes of impurity can escape detection or be mischaracterized:

• Stereoisomers — D-amino acid epimers may co-elute with the main peak because their physical properties are nearly identical; chiral chromatography or MS fragmentation is needed to detect them.
• Peptide aggregates — Non-covalent aggregates can broaden the main peak rather than appearing as a separate signal, masking a true purity reduction.
• Non-UV-absorbing contaminants — Residual salts and endotoxins are invisible to UV detection. Endotoxin testing requires a dedicated LAL assay — covered in our article on endotoxin testing for research peptides.
• Oxidation products — Methionine and cysteine residues are prone to oxidation; the modified peptide may differ in retention time by fractions of a minute, making misassignment easy in a poorly resolved separation.

These limitations reinforce why HPLC should be one component of a multi-method quality-control package rather than a standalone test. When purity, identity, and safety markers are all independently verified, researchers can have the highest possible confidence that experimental outcomes reflect the target compound's actual properties.